Zobrazeno 1 - 5
of 5
pro vyhledávání: '"José M. Fernández Navarro"'
Autor:
Romy E. van Weelderen, Kim Klein, Christine J. Harrison, Yilin Jiang, Jonas Abrahamsson, Nira Arad-Cohen, Emmanuelle Bart-Delabesse, Barbara Buldini, Barbara De Moerloose, Michael N. Dworzak, Sarah Elitzur, José M. Fernández Navarro, Robert B. Gerbing, Bianca F. Goemans, Hester A. de Groot-Kruseman, Erin Guest, Shau-Yin Ha, Henrik Hasle, Charikleia Kelaidi, Hélène Lapillonne, Guy Leverger, Franco Locatelli, Riccardo Masetti, Takako Miyamura, Ulrika Norén-Nyström, Sophia Polychronopoulou, Mareike Rasche, Jeffrey E. Rubnitz, Jan Stary, Anne Tierens, Daisuke Tomizawa, C. Michel Zwaan, Gertjan J.L. Kaspers
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 41(16), 2963-2974. American Society of Clinical Oncology
van Weelderen, R E, Klein, K, Harrison, C J, Jiang, Y, Abrahamsson, J, Arad-Cohen, N, Bart-Delabesse, E, Buldini, B, de Moerloose, B, Dworzak, M N, Elitzur, S, Fernández Navarro, J M, Gerbing, R B, Goemans, B F, de Groot-Kruseman, H A, Guest, E, Ha, S-Y, Hasle, H, Kelaidi, C, Lapillonne, H L, Leverger, G, Locatelli, F, Masetti, R, Miyamura, T, Norén-Nyström, U, Polychronopoulou, S, Rasche, M, Rubnitz, J E, Stary, J, Tierens, A, Tomizawa, D, Zwaan, C M & Kaspers, G J L 2023, ' Measurable Residual Disease and Fusion Partner Independently Predict Survival and Relapse Risk in Childhood KMT2A-Rearranged Acute Myeloid Leukemia : A Study by the International Berlin-Frankfurt-Münster Study Group ', Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 41, no. 16, pp. 2963-2974 . https://doi.org/10.1200/JCO.22.02120
JOURNAL OF CLINICAL ONCOLOGY
van Weelderen, R E, Klein, K, Harrison, C J, Jiang, Y, Abrahamsson, J, Arad-Cohen, N, Bart-Delabesse, E, Buldini, B, de Moerloose, B, Dworzak, M N, Elitzur, S, Fernández Navarro, J M, Gerbing, R B, Goemans, B F, de Groot-Kruseman, H A, Guest, E, Ha, S-Y, Hasle, H, Kelaidi, C, Lapillonne, H L, Leverger, G, Locatelli, F, Masetti, R, Miyamura, T, Norén-Nyström, U, Polychronopoulou, S, Rasche, M, Rubnitz, J E, Stary, J, Tierens, A, Tomizawa, D, Zwaan, C M & Kaspers, G J L 2023, ' Measurable Residual Disease and Fusion Partner Independently Predict Survival and Relapse Risk in Childhood KMT2A-Rearranged Acute Myeloid Leukemia : A Study by the International Berlin-Frankfurt-Münster Study Group ', Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 41, no. 16, pp. 2963-2974 . https://doi.org/10.1200/JCO.22.02120
JOURNAL OF CLINICAL ONCOLOGY
PURPOSE A previous study by the International Berlin-Frankfurt-Münster Study Group (I-BFM-SG) on childhood KMT2A-rearranged ( KMT2A-r) AML demonstrated the prognostic value of the fusion partner. This I-BFM-SG study investigated the value of flow cy
Autor:
Selim Corbacioglu, Arnaud Dalissier, Annalisa Ruggeri, Akif Yesilipek, Mikael Sundin, José M. Fernández Navarro, Franco Locatelli, Rose-Marie Hamladji, Vanderson Rocha, Maura Faraci, Concepción Herrera, O.V. Paina, Jose Rifón, E V Skorobogatova, Jacques-Emmanuel Galimard, Abdelghani Tbakhi, Franca Fagioli, Amal Al-Seraihy
HLA-haploidentical transplantation (haplo-HCT) using post-transplantation-cyclophosphamide (PT-Cy) is a feasible procedure in children with malignancies. However, large studies on Haplo-HCT with PT-Cy for childhood acute lymphoblastic leukemia (ALL)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90d9cecf05fe0b468bea29fe9792062a
http://hdl.handle.net/2318/1795257
http://hdl.handle.net/2318/1795257
Autor:
Bernward Zeller, Nira Arad-Cohen, Daniel Cheuk, Barbara De Moerloose, Jose M. Fernandez Navarro, Henrik Hasle, Kirsi Jahnukainen, Kristian Lovvik Juul-Dam, Gertjan Kaspers, Zanna Kovalova, Olafur G. Jonsson, Birgitte Lausen, Monica Munthe-Kaas, Ulrika Noren Nystrom, Josefine Palle, Ramune Pasauliene, Cornelis J. Pronk, Kadri Saks, Anne Tierens, Jonas Abrahamsson
Publikováno v:
Haematologica, Vol 999, Iss 1 (2024)
Hyperleukocytosis (HL) in pediatric acute myeloid leukemia (AML) is associated with severe complications and inferior outcome. We report results on HL patients included in the NOPHO-DBH AML 2012 study. We recommended immediate start of full dose chem
Externí odkaz:
https://doaj.org/article/8e25aca1b1344749b1c04eda6ae6c96b
Autor:
Jan Stary, Barbara Buldini, Henrik Hasle, Marta Fiocco, Barbara De Moerloose, Hester A. de Groot-Kruseman, Daisuke Tomizawa, Emmanuelle Bart-Delabesse, Takako Miyamura, Femke Verwer, Shau-Yin Ha, Gertjan J.L. Kaspers, Mareike Rasche, Hélène Lapillonne, Sarah Elitzur, Bianca F. Goemans, Kathy Jackson, Jeffrey E. Rubnitz, C. Michel Zwaan, Michael Dworzak, Guy Leverger, Franco Locatelli, José M. Fernández Navarro, Sophia Polychronopoulou, Jonas Abrahamsson, Romy E. Van Weelderen, Christine J. Harrison, Robert B. Gerbing, Nira Arad-Cohen, Charikleia Kelaidi, Kim Klein, Erin M. Guest
Publikováno v:
Blood. 138:2360-2360
Introduction KMT2A-rearranged (KMT2A-r) acute myeloid leukemia (AML) is a heterogeneous genetic subgroup with a frequency of about 25% in children with AML. At the 62 nd ASH annual meeting last year, we reported on the differences in outcome of vario
Autor:
Henrik Hasle, Hester A. de Groot-Kruseman, Femke Verwer, Franco Locatelli, Jeffrey E. Rubnitz, Christine J. Harrison, Bianca F. Goemans, Emmanuelle Bart-Delabesse, Jan Stary, Barbara Buldini, Daisuke Tomizawa, Michael Dworzak, Guy Leverger, Sophia Polychronopoulou, Mareike Rasche, Shau-Yin Ha, Kim Klein, Robert B. Gerbing, Nira Arad-Cohen, Kathy Jackson, Barbara De Moerloose, Erin M. Guest, Charikleia Kelaidi, Hélène Lapillonne, Takako Miyamura, José M. Fernández Navarro, Jonas Abrahamsson, Romy E. Van Weelderen, Sarah Elitzur, Gertjan J.L. Kaspers, Christian M. Zwaan
Publikováno v:
Blood. 136:26-27
Introduction Outcome of KMT2A-rearranged (KMT2A-r) pediatric AML (pAML) is in general poor with a 5-year probability of event-free survival (5y-pEFS) and overall survival (5y-pOS) of 44% and 56%, respectively (Balgobind et al., 2009). However, over t